share_log

Recap: Cocrystal Pharma Q4 Earnings

Recap: Cocrystal Pharma Q4 Earnings

回顧:Cocrystal Pharma第四季度收益
Benzinga ·  03/28 21:50

Cocrystal Pharma (NASDAQ:COCP) reported its Q4 earnings results on Thursday, March 28, 2024 at 08:00 AM.

Cocrystal Pharma(納斯達克股票代碼:COCP)於2024年3月28日星期四上午08點公佈了其第四季度業績。

Here's what investors need to know about the announcement.

以下是投資者需要了解的有關該公告的信息。

Earnings

收益

Cocrystal Pharma beat estimated earnings by 27.0%, reporting an EPS of $-0.44 versus an estimate of $-0.6.

Cocrystal Pharma的收益比預期高出27.0%,每股收益爲-0.44美元,而預期爲-0.6美元。

Revenue was down $0 from the same period last year.

收入比去年同期下降了0美元。

Past Earnings Performance

過去的收益表現

Last quarter the company beat on EPS by $0.12 which was followed by a 0.0% increase in the share price the next day.

上個季度,該公司的每股收益高出0.12美元,隨後第二天股價上漲了0.0%。

** Listen to the earnings announcement yourself by clicking here. **

** 點擊此處親自收聽業績公告。**

To track all earnings releases for Cocrystal Pharma visit their earnings calendar here.

要追蹤Cocrystal Pharma發佈的所有業績,請在此處訪問其業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論